As of June 6, 2022, the novel coronavirus SARS-CoV-2 that originated in Wuhan, the capital of Hubei province in China, had infected over 2.1 million people and killed 14,612 in the country. Hong Kong is currently the region with the highest active cases in China.
From Wuhan to the rest of China
In late December 2019, health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan Seafood Market. With Chinese New Year approaching, millions of Chinese migrant workers travelled back to their hometowns for the celebration. Before the start of the travel ban on January 23, around five million people had left Wuhan. By the end of January, the number of infections had surged to over ten thousand. The death toll from the virus exceeded that of the SARS outbreak a few days later. On February 12, thousands more cases were confirmed in Wuhan after an improvement to the diagnosis method, resulting in another sudden surge of confirmed cases. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. On April 17, 2020, health authorities in Wuhan revised its death toll, adding 50 percent more fatalities. After quarantine measures were implemented, the country reported no new local coronavirus COVID-19 transmissions for the first time on March 18, 2020.
The overloaded healthcare system
In Wuhan, 28 hospitals were designated to treat coronavirus patients, but the outbreak continued to test China’s disease control system and most of the hospitals were soon fully occupied. To combat the virus, the government announced plans to build a new hospital swiftly. On February 3, 2020, Huoshenshan Hospital was opened to provide an additional 1,300 beds. Due to an extreme shortage of health-care professionals in Wuhan, thousands of medical staff from all over China came voluntarily to the epicenter to offer their support. After no new deaths reported for first time, China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.
The new SARS-like coronavirus has spread around China since its outbreak in Wuhan - the capital of central China’s Hubei province. As of June 7, 2022, there were 2,785,848 active cases with symptoms in Greater China. The pandemic has caused a significant impact in the country's economy.
Fast-moving epidemic
In Wuhan, over 3.8 thousand deaths were registered in the heart of the outbreak. The total infection number surged on February 12, 2020 in Hubei province. After a change in official methodology for diagnosing and counting cases, thousands of new cases were added to the total figure. There is little knowledge about how the virus that originated from animals transferred to humans. While human-to-human transmission has been confirmed, other transmission routes through aerosol and fecal-oral are also possible. The deaths from the current virus COVID-19 (formally known as 2019-nCoV) has surpassed the toll from the SARS epidemic of 2002 and 2003.
Key moments in the Chinese coronavirus timeline
The doctor in Wuhan, Dr. Li Wenliang, who first warned about the new strain of coronavirus was silenced by the police. It was announced on February 7, 2020 that he died from the effects of the coronavirus infection. His death triggered a national backlash over freedom of speech on Chinese social media. On March 18, 2020, the Chinese government reported no new domestically transmissions for the first time after a series of quarantine and social distancing measures had been implemented. On March 31, 2020, the National Health Commission (NHC) in China started reporting the infection number of symptom-free individuals who tested positive for coronavirus. Before that, asymptomatic cases had not been included in the Chinese official count. China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country. On April 17, 2020, health authorities in Wuhan revised its death toll, adding some 1,290 fatalities in its total count.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
COVID-19: Number of Death: Year to Date: Hubei: Wuhan data was reported at 3,869.000 Person in 13 Dec 2022. This stayed constant from the previous number of 3,869.000 Person for 12 Dec 2022. COVID-19: Number of Death: Year to Date: Hubei: Wuhan data is updated daily, averaging 3,869.000 Person from Jan 2020 (Median) to 13 Dec 2022, with 1069 observations. The data reached an all-time high of 3,869.000 Person in 13 Dec 2022 and a record low of 1.000 Person in 14 Jan 2020. COVID-19: Number of Death: Year to Date: Hubei: Wuhan data remains active status in CEIC and is reported by National Health Commission. The data is categorized under High Frequency Database’s Disease Outbreaks – Table CN.GZ: COVID-19: No of Death. Clinical diagnosis included in since 12Feb 自2月12日起纳入临床诊断
As of January 1, 2023, the case fatality rate (CFR) of coronavirus COVID-19 ranged at 0.27 percent in China, lower than the global level of 1.01 percent. Health authorities in Wuhan, the Chinese epicenter, revised its death toll on April 17, adding some 1,290 fatalities to its total count. The 50 percent increase of death cases in the city raised the overall CFR in China from 4.06 percent to 5.6 percent. The Chinese Center for Disease Control and Prevention reported that mortality increased with age among infected patients.
Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.
The difficulties of death figures
This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.
Where are these numbers coming from?
The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.
The novel coronavirus that originated in the Chinese city Wuhan - the capital of Hubei province - had killed 17,826 people in Greater China. As of June 7, 2022, there were 2,785,848 active cases with symptoms in the region.
How did it spread?
In late December 2019, the health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan seafood market. The virus then spread spread rapidly to other provinces when millions of Chinese migrant workers headed home for Chinese New Year celebrations. About five billion people left Wuhan before the start of the travel ban on January 23. Right before Chinese New Year, the central government decided to put Wuhan and other cities in Hubei province on lockdown. With further travel restrictions and cancellations of public celebration events, the number of infections surpassed 80 thousand by the end of February. On March 18, 2020, China reported no new local coronavirus COVID-19 transmissions for the first time after quarantine measures had been implemented. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. After no new deaths reported for first time, the Chinese government lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.
What is COVID-19?
Coronaviruses originate in animals like camels, civets and bats and are usually not transmissible to humans. But when a coronavirus mutates, it can be passed from animals to humans. The new strain of coronavirus COVID-19 is one of the seven known coronaviruses that can infect humans causing fever and respiratory infections. China's National Health Commission has confirmed the virus can be transmitted between humans through direct contact, airborne droplets. Faecal-oral transmission could also be possible. Although the death toll of COVID-19 has surpassed that of SARS, its fatality rate is relatively low compared to other deadly coronavirus, such as SARS and MERS.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Population: Household Registration: Death Rate: Hubei: Wuhan data was reported at 6.820 ‰ in 2022. This records an increase from the previous number of 5.900 ‰ for 2021. Population: Household Registration: Death Rate: Hubei: Wuhan data is updated yearly, averaging 5.720 ‰ from Dec 2007 (Median) to 2022, with 15 observations. The data reached an all-time high of 11.620 ‰ in 2017 and a record low of 4.030 ‰ in 2007. Population: Household Registration: Death Rate: Hubei: Wuhan data remains active status in CEIC and is reported by Wuhan Municipal Bureau of Statistics. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GE: Population: Prefecture Level City: Household Registration: Natural Growth Rate.
According to a medical analysis of 44,672 confirmed COVID-19 cases in China, the overall fatality rate of the novel coronavirus was 2.3 percent. As of February 11, 2020, the fatality rate of patients aged 80 years and older was 14.8 percent.
COVID-19 rate of death, or the known deaths divided by confirmed cases, was over ten percent in Yemen, the only country that has 1,000 or more cases. This according to a calculation that combines coronavirus stats on both deaths and registered cases for 221 different countries. Note that death rates are not the same as the chance of dying from an infection or the number of deaths based on an at-risk population. By April 26, 2022, the virus had infected over 510.2 million people worldwide, and led to a loss of 6.2 million. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.
Where are these numbers coming from?
The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. Note that Statista aims to also provide domestic source material for a more complete picture, and not to just look at one particular source. Examples are these statistics on the confirmed coronavirus cases in Russia or the COVID-19 cases in Italy, both of which are from domestic sources. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.
A word on the flaws of numbers like this
People are right to ask whether these numbers are at all representative or not for several reasons. First, countries worldwide decide differently on who gets tested for the virus, meaning that comparing case numbers or death rates could to some extent be misleading. Germany, for example, started testing relatively early once the country’s first case was confirmed in Bavaria in January 2020, whereas Italy tests for the coronavirus postmortem. Second, not all people go to see (or can see, due to testing capacity) a doctor when they have mild symptoms. Countries like Norway and the Netherlands, for example, recommend people with non-severe symptoms to just stay at home. This means not all cases are known all the time, which could significantly alter the death rate as it is presented here. Third and finally, numbers like this change very frequently depending on how the pandemic spreads or the national healthcare capacity. It is therefore recommended to look at other (freely accessible) content that dives more into specifics, such as the coronavirus testing capacity in India or the number of hospital beds in the UK. Only with additional pieces of information can you get the full picture, something that this statistic in its current state simply cannot provide.
SummaryThe cumulative number of confirmed COVID-19 deaths among Maryland residents.DescriptionThe MD COVID-19 - Total Confirmed Deaths Statewide data layer is a collection of the statewide confirmed COVID-19 related deaths that have been reported each day by the Vital Statistics Administration. A death is classified as confirmed if the person had a laboratory-confirmed positive COVID-19 test result. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Probable deaths are available from the MD COVID-19 - Total Probable Deaths Statewide data layer. Update 5/27/21: The Maryland Department of Health (MDH) Vital Statistics Administration (VSA) revised the state’s COVID-19 data to include deaths that were not properly classified by medical certifiers over the past year. VSA identified these deaths as COVID-19 deaths through an information reconciliation process utilizing other sources of data. Learn more: https://health.maryland.gov/newsroom/Pages/Maryland-Department-of-Health-Vital-Statistics-Administration-issues-revision-of-COVID-19-death-data.aspxCOVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.
COVID-19 has become one of the largest epidemics in the world. As of February 11, 2020, the fatality rate of novel coronavirus COVID-19 among male patients ranged around 2.8 percent in China. The figure was based on a medical analysis of 44,672 confirmed cases.
According to a medical analysis based on 44,672 confirmed cases of the novel coronavirus COVID-19 in China published in February 2020, most patients aged between 30 and 69 years. Approximately ten percent of the surveyed patients were 29 years old or younger. The same report revealed that mortality increased with age among Chinese COVID-19 cases. The most common symptoms were fever and dry cough.
The coronavirus (COVID-19) pandemic has spread swiftly from the Chinese city Wuhan across the world. In Hong Kong, the number of active cases amounted to 260,919 with 9,389 deaths as of June 7, 2022. The financial hub was one of the places which were able to flatten the pandemic curve for a long time before the Omicron variant. To boost the low inoculation rate, Hong Kong government has widened the COVID-19 vaccine access to all residents aged 16 and older.
SummaryThe cumulative number of probable COVID-19 deaths among Maryland residents by age: 0-9; 10-19; 20-29; 30-39; 40-49; 50-59; 60-69; 70-79; 80+; Unknown.DescriptionThe MD COVID-19 - Probable Deaths by Age Distribution data layer is a collection of the statewide confirmed and probable COVID-19 related deaths that have been reported each day by the Vital Statistics Administration by designated age ranges. A death is classified as probable if the person's death certificate notes COVID-19 to be a probable, suspect or presumed cause or condition. Probable deaths are not yet been confirmed by a laboratory test. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Confirmed deaths are available from the MD COVID-19 - Confirmed Deaths by Age Distribution data layer.COVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.
SummaryThe cumulative number of probable COVID-19 deaths among Maryland residents.DescriptionThe MD COVID-19 - Total Probable Deaths Statewide data layer is a collection of the statewide probable COVID-19 related deaths that have been reported each day by the Vital Statistics Administration. A death is classified as probable if the person's death certificate notes COVID-19 to be a probable, suspect or presumed cause or condition. Probable deaths are not yet been confirmed by a laboratory test. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Confirmed deaths are available from the MD COVID-19 - Total Confirmed Deaths Statewide data layer.COVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.
SummaryThe cumulative number of probable COVID-19 deaths among Maryland residents by gender: Female; Male; Unknown.DescriptionThe MD COVID-19 - Probable Deaths by Gender Distribution data layer is a collection of the statewide confirmed and probable COVID-19 related deaths that have been reported each day by the Vital Statistics Administration by gender. A death is classified as probable if the person's death certificate notes COVID-19 to be a probable, suspect or presumed cause or condition. Probable deaths are not yet been confirmed by a laboratory test. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Confirmed deaths are available from the MD COVID-19 - Confirmed Deaths by Gender Distribution data layer.COVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.
After the outbreak of the coronavirus (COVID-19) in Italy, many people died after contracting the infection. As of May 2023, the mortality rate for female patients in Italy was 0.6 percent, the corresponding figure for male patients was 0.9 percent. The chart shows how this gap was recorded among all age groups.
Italy's death toll was one of the most tragic in the world. In the last months, however, the country saw the end to this terrible situation: as of May 2023, roughly 84.7 percent of the total Italian population was fully vaccinated.
The virus originated in Wuhan, a Chinese city populated by millions and located in the province of Hubei. More statistics and facts about the virus in Italy are available here. For a global overview visit Statista's webpage exclusively dedicated to coronavirus, its development, and its impact.
CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
This fileset contains 2 data files. Raw Data.xlsx is in .xlsx file format and Difference statistics.docx in .docx file format.Dataset Raw Data.xlsx contains daily data of the cumulative number of infected cases, cured cases and death, and the climate indicators including average temperature, wind speed, relative humidity, precipitation and the air quality index (AQI) in 12 cities in China during the period of Jan 23rd to Feb 22nd, 2020. The 12 cities for which data are reported, are: Guangzhou, Chongqing, Hefei, Shanghai, Beijing, Harbin, Xinyang, Changsha, Nanchang, Xianning, Shenzhen and Wenzhou.Dataset Difference statistics.docx contains the results of the statistical analyses. Data were analysed by SPSS 21.0.Study aims and methodology: The purpose of the present study was to explore the correlation between the novel coronavirus disease 2019 (COVID-19) and climate indicators in cities of China.Twelve cities including Guangzhou, Chongqing, Hefei, Shanghai, Beijing, Harbin, Xinyang, Changsha, Nanchang, Xianning, Shenzhen, Wenzhou were chosen as the study objects. Daily officially reported total number of infected cases, cured cases and death in the 12 cities during the period ofJan 23 to Feb 22, 2020, were obtained. The data of climate indicators including average temperature, wind speed, relative humidity, precipitation and air quality index (AQI) in the cities above were obtained from the National Meteorological Center (http://www.nmc.cn/publish/observations/hourly-precipitation.html). Wuhan was excluded as it was the first place reported the COVID-19 case. Also Wuhan had the severe burst and extremely dense crowds.For more details on the methodology and statistical analysis, please read the related article.
Attribution-NonCommercial-NoDerivs 4.0 (CC BY-NC-ND 4.0)https://creativecommons.org/licenses/by-nc-nd/4.0/
License information was derived automatically
To date, one million confirmed cases of SARS-CoV-2 virus have been reported worldwide with a death toll of over 50,000 (1). Particular concern has been raised regarding the exposure of healthcare professionals. Early reports from the Wuhan province in China described up to 29% infection rates among healthcare professionals before the use of personal Protection equipment (PPE) was fully established (2). Several measures are being established with regard the correct use of PPE and reduction in aerosol generating procedures. However to the authors’ knowledge, no specific guidance is available regarding the potential risk of aerosolization of SARS-Cov-2 virus via chest drains in patients with active air leak.Viral Spread and Air LeakThe SARS-CoV-2 virus, which leads to COVID-19, has been demonstrated to remain viable in aerosol form and is transmitted by droplets (3). Despite the current coronavirus pandemic, we are still faced with patients requiring chest tube drainage for pneumothorax on cardiothoracic and respiratory wards, as well as in critical care units. Whilst drains may be inserted with lower risk of viral spread for simple pleural effusions, the authors fear there may be a high risk of aerosolization in cases of pneumothorax with active air leak, whether that be primary, secondary, or indeed iatrogenic in mechanically ventilated patients requiring high PEEP ventilation such as in patients with COVID-19.Citing a recent example of a postoperative thoracic surgical patient in the authors’ unit who had a prolonged air leak and who later was found to be positive for SARS-CoV-2, they have considered the implications of aerosolization from the chest drain and in particular the chest drain bottle. This may represent an under-recognised means of viral spread, which may put patients and health care professionals at risk of infection.Chest Drains and Risk of AerosolizationTraditional under water seal chest drain bottles have a port which allows attachment to low pressure wall suction. Most modern drain systems also have a safety valve which opens to air should the suction be accidentally turned off in the presence of an air leak, to avoid creating a closed system effect which could lead to a tension pneumothorax. If the drain bottle is not attached to suction, then the port is open to the atmosphere.When air leaks into a chest drain bottle, it causes the fluid inside to bubble. Given the aerosolization that is likely to occur inside the drain bottle, which then escapes through the suction port or safety valve, this may be a potentially important mode of viral transmission. Alternatives to a traditional chest drain bottle include a number of different digital chest drainage systems. Whilst these do not have a port open to room air, they are not closed systems and the air escapes from the system into the air without any specific viral filter.A number of patients on the authors’ unit’s thoracic ward have since tested positive for COVID-19. Whilst the patient with the air leak may not have been the source of infection, they feel this should be considered. In their patient, a digital chest drainage system was being used.In light of this, and until further robust evidence regarding the volume of aerosolization from a chest drain bottle emerges, the authors would recommend the use of closed drainage systems, i.e. connecting the standard drain bottle to wall suction to avoid the spread of viral load via aerosolization. However, in order to obtain this, the safety valve will have to be occluded with potential risk of increasing intrathoracic pressure and cause tension, should the suction system be switched off whilst still connected to the bottle. Furthermore, keeping the bottle attached to wall suction will significantly limit the mobilization of patients, which is a significant risk factor for postoperative complications in the surgical patient.A Bespoke Chest Drain SystemIn order to overcome this, a possible consideration would be to attach an antimicrobial filter, such as those used in ventilator circuits, to the chest drain suction port leaving the drain off suction and occluding the safety valve. Connecting the filter directly to the chest drain should be discouraged, as fluid and moisture directly from the chest cavity are likely to interfere with the functioning of the filter.Therefore, the authors designed a bespoke drainage system using the Filta-Guard™ ventilator filter from Intersurgical Ltd© 2020 and a segment of endotracheal tube to use in their unit (Figures 1 and 2). The filter guarantees a filtration efficiency of >99.999% as tested on Hepatitis C and Mycobacterium tuberculosis in addition to standard test micro-organisms (4). The SARS-Cov-2 diameter varies from 60 to 140 nm, and therefore is larger than hepatitis C virus, which has an average diameter of about 55 nm. The authors postulated that given the larger size compared to Hep C virus, this filter should be effective in preventing flow of SARS-Cov-2 across the filter, however to their knowledge, this has not been clinically tested. Regarding the possible resistance to the system added by the filter and related risk of building up pressure in the chest cavity, they believe this should be marginal. Published data suggest the above filter would generate a resistance against the passage of 30L/min of 1.0cm H2O and 2.3cm H2O at 60L/min (4).ConclusionsThe efficacy of this chest drain modification clearly needs to be further investigated, however, given the current pandemic, any method of reducing viral spread should be considered.Acknowledgements: The authors would like to acknowledge Mr Panagiotis Theodoropoulos and Mr Duncan Steele, Specialist Registrars in Thoracic Surgery at Hammersmith Hospital, London.ReferencesJohns Hopkins University & Medicine. COVID-19 Map. https://coronavirus.jhu.edu/map.html. Published 2020. Accessed April 2, 2020.Chen W, Huang Y. To protect healthcare workers better, to save more lives. Anesth Analg. 2020:1-15. doi:10.1213/ANE.0000000000004834van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020. doi:10.1056/NEJMc2004973Systems ICR. Filta-GuardTM range - high efficiency. https://www.intersurgical.com/products/airway-management/filtaguard-range-high-efficiency#1944000. Published 2020. Accessed April 2, 2020.
This statistic shows the fatality rate of COVID-19 by age groups in France. As of February 15, 2020, the fatality rate of patients aged 75 years and older was 10.3 percent. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
As of June 6, 2022, the novel coronavirus SARS-CoV-2 that originated in Wuhan, the capital of Hubei province in China, had infected over 2.1 million people and killed 14,612 in the country. Hong Kong is currently the region with the highest active cases in China.
From Wuhan to the rest of China
In late December 2019, health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan Seafood Market. With Chinese New Year approaching, millions of Chinese migrant workers travelled back to their hometowns for the celebration. Before the start of the travel ban on January 23, around five million people had left Wuhan. By the end of January, the number of infections had surged to over ten thousand. The death toll from the virus exceeded that of the SARS outbreak a few days later. On February 12, thousands more cases were confirmed in Wuhan after an improvement to the diagnosis method, resulting in another sudden surge of confirmed cases. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. On April 17, 2020, health authorities in Wuhan revised its death toll, adding 50 percent more fatalities. After quarantine measures were implemented, the country reported no new local coronavirus COVID-19 transmissions for the first time on March 18, 2020.
The overloaded healthcare system
In Wuhan, 28 hospitals were designated to treat coronavirus patients, but the outbreak continued to test China’s disease control system and most of the hospitals were soon fully occupied. To combat the virus, the government announced plans to build a new hospital swiftly. On February 3, 2020, Huoshenshan Hospital was opened to provide an additional 1,300 beds. Due to an extreme shortage of health-care professionals in Wuhan, thousands of medical staff from all over China came voluntarily to the epicenter to offer their support. After no new deaths reported for first time, China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.